Atlas Trials

Ranolazine for the Prevention of Atrial Fibrillation After Electrical Cardioversion

Clinical trial NCT01349491 · TERMINATED

Trial details

NCT number
NCT01349491
Sponsor
University of Oklahoma
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Atrial Fibrillation
Start date
2012-03-01
Primary completion
2014-06-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.